Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus

Dipeptidyl peptidase-4 inhibitors (DPP-4i) provide a unique antihyperglycemic effect by regulating incretin peptides in type 2 diabetes mellitus (T2DM) patients who are inadequately controlled with insulin the...

Source: Diabetology and Metabolic Syndrome - August 26, 2021 Category: Endocrinology Authors: Xin Wei, Yu Bai, Zhuo Wang, Xiaohong Zheng, Zening Jin and Xin Liu Tags: Research Source Type: research